Literature DB >> 23098467

Crocetin induces cytotoxicity in colon cancer cells via p53-independent mechanisms.

Cai-Yan Li1, Wen-Feng Huang, Qun-Li Wang, Fan Wang, E Cai, Bing Hu, Jia-Cheng Du, Jing Wang, Rong Chen, Xiao-Jing Cai, Jing Feng, Hui-Hui Li.   

Abstract

OBJECTIVE: Crocin has been proposed as a promising candidate for cancer chemoprevention. The purpose of this investigation was to investigate the chemopreventive action and the possible mechanisms of crocin against human colon cancer cells in vitro.
METHODS: Cell proliferation was examined using MTT assay and the cell cycle distribution fractions were analyzed using flow cytometric analysis after propidium iodide staining. Apoptosis was detected using the TUNEL Apoptosis Detection Kit with laser scanning confocal microscope. DNA damage was assessed using the alkaline single-cell gel electrophoresis assay, while expression levels of p53, cdk2, cyclin A and P21 were examined by Western blot analysis.
RESULTS: Treatment of SW480 cells with crocetin (0.2, 0.4, 0.8 mmol/L) for 48 h significantly inhibited their proliferation in a concentration-dependent manner. Crocetin (0.8 mmol/L) significantly induced cell cycle arrest through p53-independent mechanisms accompanied by P21 induction. Crocetin (0.8 mmol/L) caused cytotoxicity in the SW480 cells by enhancing apoptosis and decreasing DNA repair capacity in a time-dependent manner.
CONCLUSIONS: This report provides evidence that crocetin is a potential anticancer agent, which may be used as a chemotherapeutic drug.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23098467     DOI: 10.7314/apjcp.2012.13.8.3757

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  18 in total

Review 1.  Mechanisms of drug resistance in colon cancer and its therapeutic strategies.

Authors:  Tao Hu; Zhen Li; Chun-Ying Gao; Chi Hin Cho
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

2.  Crocin inhibits cell proliferation and enhances cisplatin and pemetrexed chemosensitivity in lung cancer cells.

Authors:  Shuangshuang Chen; Shuang Zhao; Xinxing Wang; Luo Zhang; Enze Jiang; Yuan Gu; Anna Junjie Shangguan; Hong Zhao; Tangfeng Lv; Zhenghong Yu
Journal:  Transl Lung Cancer Res       Date:  2015-12

3.  Comparative anticancer activity analysis of saffron extracts and a principle component, crocetin for prevention and treatment of human malignancies.

Authors:  Sevgi Gezici
Journal:  J Food Sci Technol       Date:  2019-08-17       Impact factor: 2.701

4.  Anticancer effects of crocetin in human esophageal squamous cell carcinoma KYSE-150 cells.

Authors:  Sheng Li; Sheng Jiang; Wei Jiang; Yue Zhou; Xiu-Yin Shen; Tao Luo; Ling-Ping Kong; Hua-Qiao Wang
Journal:  Oncol Lett       Date:  2015-01-13       Impact factor: 2.967

Review 5.  Therapeutic effects of saffron (Crocus sativus L.) in digestive disorders: a review.

Authors:  Alireza Rezaee Khorasany; Hossein Hosseinzadeh
Journal:  Iran J Basic Med Sci       Date:  2016-05       Impact factor: 2.699

6.  Synergistic anticancer effect of combined crocetin and cisplatin on KYSE-150 cells via p53/p21 pathway.

Authors:  Sheng Li; Xiu-Yin Shen; Ting Ouyang; Yuhua Qu; Tao Luo; Hua-Qiao Wang
Journal:  Cancer Cell Int       Date:  2017-10-30       Impact factor: 5.722

7.  Antiproliferative Activity of Crocin Involves Targeting of Microtubules in Breast Cancer Cells.

Authors:  Rupali R Hire; Shalini Srivastava; Melissa B Davis; Ananda Kumar Konreddy; Dulal Panda
Journal:  Sci Rep       Date:  2017-03-24       Impact factor: 4.379

8.  Curcumin and vitamin E protect against adverse effects of benzo[a]pyrene in lung epithelial cells.

Authors:  Wenbin Zhu; Meghan M Cromie; Qingsong Cai; Tangfeng Lv; Kamaleshwar Singh; Weimin Gao
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

9.  Crocetin exploits p53-induced death domain (PIDD) and FAS-associated death domain (FADD) proteins to induce apoptosis in colorectal cancer.

Authors:  Pallab Ray; Deblina Guha; Juni Chakraborty; Shuvomoy Banerjee; Arghya Adhikary; Samik Chakraborty; Tanya Das; Gaurisankar Sa
Journal:  Sci Rep       Date:  2016-09-13       Impact factor: 4.379

Review 10.  Nature curing cancer - review on structural modification studies with natural active compounds having anti-tumor efficiency.

Authors:  Gurpreet Kaur; Neelam Verma
Journal:  Biotechnol Rep (Amst)       Date:  2015-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.